NEW YORK (GenomeWeb) – The GenomeWeb Index rose more than 5 percent in September, outperforming the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, and clawing back the 2 percent drop it saw in August.

All but three of the stocks in the Index — which now tracks 29 firms in the omics research tools and molecular diagnostics space — rose in September, many by double digits. The Dow lost half a percent in September while the Nasdaq rose nearly 2 percent. The Nasdaq Biotech Index rose 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.